The decision to withdraw the use of a number of dementia drugs following a cost-effectiveness review by the government’s medication watchdog may have fuelled the use of antipsychotics to ‘manage’ people with the condition, the All Party Parliamentary Group on Dementia was told last month.In reports made to the group by two leading Alzheimer’s campaign…